Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Here’s Why

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares gapped down prior to trading on Monday . The stock had previously closed at $17.18, but opened at $16.03. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.06, with a volume of 8,957 shares changing hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. UBS Group raised their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a report on Monday, January 27th. William Blair restated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 5.6%

The stock has a 50 day simple moving average of $17.11.

Institutional Investors Weigh In On Telix Pharmaceuticals Limited American Depositary Shares

An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. Private Advisor Group LLC bought a new stake in Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 10,140 shares of the company’s stock, valued at approximately $170,000.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.